🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of ruxolitinib wh...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-08-16
Trial ID
NCT03874052
Evaluate and study the immunologic changes to the ocular surface in cancer ...
Status
Recruiting
Location
Geenebaum Cancer Center, University of Maryland Medical Center
Start Date
2022-04-27
Trial ID
NCT04946721
Treatments Being Tested
Myeloma is a bone marrow cancer with over 5000 patients diagnosed in the UK...
Status
Recruiting
Location
The Royal Marsden NHS Foundation Trust
Start Date
2020-07-22
Trial ID
NCT05968417
Treatments Being Tested
This phase II trial tests how well epcoritamab in combination with rituxima...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-07-27
Trial ID
NCT07365306
This phase I trial studies the side effects and best dose of TAK-243 in tre...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2025-03-12
Trial ID
NCT03816319
This clinical trial studies the utilization of glutamine by the bone marrow...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-06-02
Trial ID
NCT03119883
This pilot clinical trial studies the side effects of sorafenib tosylate be...
Status
Completed
Location
University of Maryland/Greenebaum Cancer Center
Start Date
2012-01-13
Trial ID
NCT01578109
Treatments Being Tested
This is a clinical trial, unicentric, prospective, controlled, randomized, ...
Status
Unknown
Location
Institut de Terapia Regenerativa Tissular
Start Date
2017-12-13
Trial ID
NCT03454737
Treatments Being Tested
This phase II trial compares mosunetuzumab to the usual treatment (rituxima...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2024-01-23
Trial ID
NCT05886036
This phase II trial tests the effect of venetoclax in combination with stan...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-10-01
Trial ID
NCT07734038